Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI -1.11%77 ROE % is 7.75% as of Mar. 2026, which is 52% below its 10-year median of 16.29. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 77/100 and a GF Value™ of ₹120.61 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 798 Medical Devices & Instruments companies, QMS Medical Allied Services ranks better than 77.94% on this metric.
The historical rank and industry rank for QMS Medical Allied Services's ROE % or its related term are showing as below:
NSE:QMSMEDI'
s ROE % Range Over the Past 10 Years
Min: 11.27 Med: 16.29 Max: 73.45
Current: 11.27
During the past 7 years, QMS Medical Allied Services's highest ROE % was 73.45%. The lowest was 11.27%. And the median was 16.29%.
NSE:QMSMEDI's ROE % is ranked better than 77.94% of 798
companies
in the Medical Devices & Instruments industry
Industry Median: 2.51
vs NSE:QMSMEDI: 11.27
QMS Medical Allied Services (NSE:QMSMEDI) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's ROE % distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
QMS Medical Allied Services (NSE:QMSMEDI) has a ROE % of 7.75% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on QMS Medical Allied Services and its competitors. This is 52% below median its historical median of 16.29. Over the past decade, QMS Medical Allied Services' ROE % has ranged from 11.27 to 73.45. According to the industry distribution chart, QMS Medical Allied Services ranks #176 out of 798 companies in the Medical Devices & Instruments industry, placing it in the top 22.1%.
Is QMS Medical Allied Services' ROE % too high?
QMS Medical Allied Services' current ROE % of 7.75% is 52% below median its 10-year median of 16.29. Over the past 10 years, this metric has ranged from a low of 11.27 to a high of 73.45. The Medical Devices & Instruments industry median ROE % is 2.51. QMS Medical Allied Services' value of 7.75% is 208.8% above this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #176 out of 798 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, QMS Medical Allied Services has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #176 out of 798 companies for ROE %. This places QMS Medical Allied Services in the top 22% of its industry — outperforming the majority of peers. The industry median ROE % is 2.51. QMS Medical Allied Services' value of 7.75% is 208.8% above this benchmark. Historically, QMS Medical Allied Services' own ROE % has ranged from 11.27 to 73.45 over the past decade. While the company's 10-year median is 16.29 vs. the industry median of 2.51, QMS Medical Allied Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.51, based on 798 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current ROE % of 7.75% is 208.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current ROE % is 7.75%, which is 52% below median its own 10-year median of 16.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹120.61, compared to a current price of ₹106.96 — trading 11.3% below its estimated fair value. The current ROE % is 7.75%, which is 52% below median its 10-year median of 16.29 and 208.8% above the Medical Devices & Instruments industry median of 2.51. QMS Medical Allied Services' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current ROE % is 7.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be undervalued.
The current stock price of ₹106.96 is trading 11.3% below its estimated GF Value™ of ₹120.61.
GuruFocus considers QMS Medical Allied Services to be Modestly Undervalued.
Key valuation signals for NSE:QMSMEDI:
ROE %: 7.75% (52% below median its 10-year median of 16.29)
GF Value™: ₹120.61 vs. price of ₹106.96 (11.3% below fair value)
Industry Position: 208.8% above the Medical Devices & Instruments median (#176 of 798)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
77GF Score
Get the complete analysis for NSE:QMSMEDI
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
